These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 6373989)

  • 1. Aldosterone and other mineralocorticoids in Bartter's syndrome.
    Saruta T; Fujimaki M; Senba S; Saito I; Konishi K
    J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma-aldosterone and renin activity in Bartter's syndrome (author's transl)].
    Rössler R
    Dtsch Med Wochenschr; 1975 Nov; 100(47):2443-8. PubMed ID: 171132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the pathogenesis of Bartter's syndrome: report of studies in a patient with this disorder.
    Norby L; Mark AL; Kaloyanides GJ
    Clin Nephrol; 1976 Sep; 6(3):404-13. PubMed ID: 991467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bartter's syndrome: seven cases in siblings. Hypothesis of mild forms (author's transl)].
    Nivet H; Rolland JC; Lebranchu Y; Dray F; Benatre A; Drucker J; Grenier B; Bagros P
    Nouv Presse Med; 1980 Apr; 9(18):1287-90. PubMed ID: 6990383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal tubular reabsorption of chloride in Bartter's syndrome and other conditions with hypokalemia.
    Rodriguez Portales JA; Delea CS
    Clin Nephrol; 1986 Dec; 26(6):269-72. PubMed ID: 3802593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's syndrome.
    Griffing GT; Aurecchia SA; Sindler BH; Melby JC
    J Clin Pharmacol; 1982; 22(11-12):505-12. PubMed ID: 6761369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bartter's syndrome. Differentiation into two clinical groups.
    Robson WL; Arbus GS; Balfe JW
    Am J Dis Child; 1979 Jun; 133(6):636-8. PubMed ID: 35973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactive renin and aldosterone in Bartter's syndrome.
    McKenzie IM; Heiman D; Winter JS; McKenzie JK
    Clin Invest Med; 1987 Jul; 10(4):303-8. PubMed ID: 3308240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic peptide levels during angiotensin infusion and indomethacin administration are consistent with angiotensin-mediated regulation in man.
    Klemm SA; Tunny TJ; Gordon RD
    J Hypertens Suppl; 1987 Dec; 5(5):S75-8. PubMed ID: 2965235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bartter's syndrome: a metabolic study.
    Ross D; Weber HP
    J Kans Med Soc; 1976 Sep; 77(9):378-82. PubMed ID: 965791
    [No Abstract]   [Full Text] [Related]  

  • 11. [The influence of saralasine on blood pressure and renal function in Bartter's syndrome and decompensated hepatic cirrhosis (author's transl)].
    Klaus D; Witzgall H; Zehner J; Dürr H; Lange H
    Dtsch Med Wochenschr; 1976 Sep; 101(37):1357-9. PubMed ID: 954592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome.
    Horký K; Schreiber V; Dvoráková J
    Exp Clin Endocrinol; 1984 Jul; 84(1):105-11. PubMed ID: 6090182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bartter's syndrome--observations on the pathophysiology.
    Solomon LR; Bobinski H; Astley P; Goldby FS; Mallick NP
    Q J Med; 1982; 51(203):251-70. PubMed ID: 7146310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition.
    Vinci JM; Gill JR; Bowden RE; Pisano JJ; Izzo JL; Radfar N; Taylor AA; Zusman RM; Bartter FC; Keiser HR
    J Clin Invest; 1978 Jun; 61(6):1671-82. PubMed ID: 96139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Increased renal prostaglandin E2 secretion in Bartter's syndrome].
    Schwarz HA; Weidmann P; Messerli FH; Zia PK; Flammer J; Reubi RC
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1870-2. PubMed ID: 929154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some aspects of urinary kallikrein in a patient with Bartter's syndrome.
    Tamura Y; Matsuda Y; Yamada K; Takagi T; Nishikawa T; Watanabe M; Mikami K; Moriya H; Kumagai A
    Adv Exp Med Biol; 1979; 120B():515-24. PubMed ID: 517245
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis].
    Favre L; Glasson P; Flory ED; Dray F; Vallotton MB
    Schweiz Med Wochenschr; 1979 Feb; 109(5):142-7. PubMed ID: 441720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma and urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome (author's transl)].
    Hornych A
    Nephrologie; 1980; 1(3):113-6. PubMed ID: 6945487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
    Kater CE; Biglieri EG; Rost CR; Schambelan M; Hirai J; Chang BC; Brust N
    J Clin Endocrinol Metab; 1985 Feb; 60(2):225-8. PubMed ID: 2981240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bartter's syndrome--a case study with special reference to the role of renal prostaglandins and the renin-angiotensin-aldosterone system].
    Sato M; Abe K; Hoshima M; Chiba S; Ritsu K
    Horumon To Rinsho; 1979 Jan; 27(1):51-7. PubMed ID: 428121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.